HEAMONINE

Lactation Diabetes Female likely to be pregnant Pregnancy Hepatitis Male of childbearing age Hepatic impairment Renal impairment Important tumour mass Newborn exposed in utero to the medicine Obesity Digestive pathology Elderly Subject at risk of hepatopathies Subject under 18 Proliferative tumour.

The laboratory is a complex of the cells of the cell.

Preclinical data suggest that the biological activity of the vedotin brentuximab is the result of a multistage process.

The binding of the

CD30 antigen to the cell surface triggers the internalization of the CD30 complex which is then transferred to the cell compartment.

Within the cell, the active substance of the tumour cells is the CD30-representative CD-representative CD-representative CD-representative CD-representative DNA-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive.

• Neutropenia (Very common)
• ALT (increase) (Common)
• ASAT (increase) (Common)
• Hyperglycaemia (Common)
• Tumor lysis syndrome (Uncommon)
• Alopecia (Common)
• Lyell's syndrome (Uncommon)
• Pruritus (Very common)
• Rash (Very common)
• Stevens-Johnson Syndrome (Uncommon)
• Frisher (Common)
• Fever (Very common)
• Fatigue (Very common)
• Anemia (Common)
• Febrile neutropenia (Uncommon)
• Thrombocytopenia (Common)
• Anaphylactic reaction (Uncommon)
• DRESS syndrome Staphylococcal bacteria (Uncommon)
• Bacteriaemia Pneumonia in Pneumocystis jirovecii (Uncommon)
• Oral candidiasis (Common)
• Reactivation of cytomegalovirus infection (Uncommon)
• Zona (Common)
• Cytomegalovirus infection (Uncommon)
• Herpes (Common)
• Infection (Very common)
• Sepsis (Uncommon)
• Opportunistic infection
• Infusion-related reaction (Very common)
• Extravasation at the injection site Anorexia (Very common)
• Weight (decrease) (Very common)
• Feeling dizzy (Common)
• Stomatitis (Very common)
• Insomnia (Very common)
• Septic shock (Common)
• Constipation (Very common)
• Acute Pancreatitis (Uncommon)
• Nausea (Very common)
• Diarrhoea (Very common)
• Abdominal pain (Very common)
• Vomiting (Very common)
• Sleeping (Common)
• Bone pain (Very common)
• Muscle pain (Very common)
• Joint pain (Very common)
• Peripheral sensory neuropathy (Very common)
• Demyelinating polyneuropathy (Uncommon)
• Peripheral motor neuropathy (Very common)
• Progressive multifocal leukoencephalopathy Headache Neuropathy Peripheral neuropathy
• Cough (Very common)
• Dyspnoea (Very common)
• Pneumonia (Common)
• Upper respiratory tract infection (Very common).